Back to Trades
Total Value
$77.7K
Net $77.3K sold
Filing Date
Jul 20, 2026
1 transaction
Sales
$77.3K
1 transaction
Trade Summary
On Jul 17, 2026, Herrmann Ken, Insider, sold $77.7K of Aktis Oncology, Inc. (AKTS) across 1 transaction. The filing covers Common Stock and reflects net selling of $77.3K. Reported prices ranged from $0.08 to $25.21. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Aktis Oncology, Inc.
- Ticker Symbol
- AKTS
- CIK
- 0002035832
Insider Information
- Name
- Herrmann Ken
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jul 20, 2026
- Transaction Date
- Jul 17, 2026
- Accession Number
- 0001193125-26-309115
- Form Type
- 4
- Net Trading Amount
- -$77.3K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | Common Stock | 3,065 | $0.08 | Exercise | $245 |
| Jul 17, 2026 | Common Stock | 3,065 | $25.21 | Sale | $77.3K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 17, 2026 | AKTS derivative | 3,065 | $0.08 | Exercise | $245 |
Want live alerts when Herrmann Ken trades again?
Download Insider Trades to track AKTS, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.4950, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- (F2)These options have vested in full.